N-acetylcysteine
FWA00000312-2
Phase 1 small_molecule completed
Quick answer
N-acetylcysteine for Parkinson's Disease is a Phase 1 program (small_molecule) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx UK Limited
- Indication
- Parkinson's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed